Ezetimib Rosuvastatin Zentiva 10 mg / 10 mg

Ezetimib Rosuvastatin Zentiva 10 mg / 10 mg is a medicine authorised by Swissmedic under authorisation number 68526. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 September 2022 and the authorisation is limited until 28 September 2027. ATC code C10BA06 places the medicine in the group Lipid modifying agents.

  • Dispensing category B
  • Authorisation number 68526
  • ATC C10BA06
  • Synthetic medicines
Authorisation data
Authorisation number68526
NameEzetimib Rosuvastatin Zentiva 10 mg / 10 mg
Full nameEzetimib Rosuvastatin Zentiva 10 mg / 10 mg, Filmtabletten
Authorisation holderHelvepharm AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC10BA06
First authorisation29 September 2022
Authorisation validity28 September 2027
Strengths
No.NameDispensing categoryAuthorisation date
1Ezetimib Rosuvastatin Zentiva 10 mg / 10 mg, FilmtablettenB29 September 2022
2Ezetimib Rosuvastatin Zentiva 10 mg / 20 mg, FilmtablettenB29 September 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Tablette(n)C10BA0607.12.0.B
290Tablette(n)C10BA0607.12.0.B
330Tablette(n)C10BA0607.12.0.B
490Tablette(n)C10BA0607.12.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ezetimib Rosuvastatin Zentiva 10 mg / 10 mg authorised in Switzerland?

Yes. Ezetimib Rosuvastatin Zentiva 10 mg / 10 mg is authorised by Swissmedic under authorisation number 68526, data as of 01 September 2026. The authorisation is limited until 28 September 2027.

Which dispensing category does Ezetimib Rosuvastatin Zentiva 10 mg / 10 mg have?

Ezetimib Rosuvastatin Zentiva 10 mg / 10 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ezetimib Rosuvastatin Zentiva 10 mg / 10 mg?

The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com